Next-Generation DMD Care: Harnessing New Therapies and Enhancing Patient Outcomes

This Live Virtual CME activity will take place on Thursday, October 30, 2025 at 11:30am – 12:45pm Pacific Time, and is eligible for AMA PRA Category 1 Credits™ only to those who attend the activity virtually on this date. 


Program Introduction

Join Emma Ciafaloni, MD, FAAN and Aravindhan Veerapandiyan, MD for this one-hour, live, virtual, interactive, case-based program designed to provide a comprehensive overview of current issues in the diagnosis and management of patients with Duchenne’s muscular dystrophy. It includes a patient perspective on living with the disease.

Learning Objectives

  • Understand the genetic and molecular underpinnings of Duchenne muscular dystrophy
  • Integrate expert-recommended diagnostic and therapeutic approaches in the management of Duchenne muscular dystrophy.
  • Develop comprehensive patient care plans that focus on improving long-term health and quality of life

Available Credit

  • 1.25 AMA PRA Category 1 CreditTM
  • 1.25 Participation

Please complete the pretest before attending the live virtual activity on Thursday, October 30, 2025.